Blueprint Medicines to Present at the 22nd Annual NewsMakers in the Biotech Industry Conference
A live webcast of the event will be available by visiting the Investors section of the Blueprint Medicines website at www.blueprintmedicines.com. An archived replay of the webcast will be available on the Company's website for 30 days after the conference.
About Blueprint Medicines
Blueprint Medicines makes kinase drugs to treat patients with genomically defined diseases. Led by a team of industry innovators, Blueprint Medicines integrates a novel target discovery engine and a proprietary compound library to understand the blueprint of cancer and craft highly selective therapies. This empowers the Blueprint Medicines team to develop patient-defined medicines aimed at eradicating cancer.
Logo - http://photos.prnewswire.com/prnh/20150605/221118LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/blueprint-medicines-to-present-at-the-22nd-annual-newsmakers-in-the-biotech-industry-conference-300135842.html
SOURCE
Investor Relations: Hannah Deresiewicz, Stern Investor Relations, Inc., 212-362-1200, hannahd@sternir.com; Media Relations: Naomi Aoki, Ten Bridge Communications, Inc., 617-283-4298, naomi@tenbridgecommunications.com